The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Professional Services Scientific, Architectural And Engineering Technical Activities Scientific Research And Development 72.11 - Research and experimental development on biotechnology
400 jobs Number of planned job losses
Announcement Date
11 February 2020
Employment effect (start)
11 February 2020
Foreseen end date
1 July 2020
Description
In February 2020, the German pharmaceutical company Bayer announced that it will outsource one part of its research to Nuvisan, which will affect 400 employees from Bayer's unit in Berlin. The outsourced research department focuses on small molecular agents. Details on the deal, which is expected to be finalised in mid-2020, have not been published. Nuvisan plans to take on all 400 employees from Bayer's unit.
Currently, Nuvisan has around 400 employees in Germany.
Eurofound (2020), Bayer, Outsourcing in Germany, factsheet number 100060, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/100060.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
